Calling all trainees researching #aging and age-related diseases 📣 Register for GLAM 2026, a trainee-focused event bringing together the geroscience community in the greater LA area.
📍California Science Center
📆 September 4, 2026
Register to attend: https://t.co/xj9Rjs2jCw
CC:
@ucimind@UCIrvine@UCLAHealth@USCDornsife@UCSB@Caltech@CedarsSinai
#StemCellAging #RegenerativeMedicine #BrainAging #Immunity #AntiAging
A multidisciplinary dementia cost project led by USC researchers provides updated estimates of the financial toll on patients, care partners and society.
https://t.co/I6ogbMI3Dl
.@USCLeonardDavis new research shows that low-tech letters can lead to better practices around high-risk medications. This research was led by Assistant Professors Michelle Keller (@michelleskeller) and Mireille Jacobson (@MJhealthecon). #deprescribing
https://t.co/RXJoi6NfNZ
.@CedarsSinai finds an increase in overtreatment of prostate cancer in men with average life expectancies of less than 10 years; this trend is problematic because they might not live long enough to receive the benefits of the aggressive treatment.
https://t.co/dIre2pTXef
.@UCLAHealth researchers awarded $2.5 million grant to increase lung cancer screenings in underserved communities. The award supports access to screening for marginalized groups in Los Angeles, where screening rates remain low in the 5% - 6% range.
https://t.co/vYYuHtwnVY
.@CedarsSinai study finds that the hippocampus holds key cells critical for both working & long-term memory. Previously it was assumed both forms of memory were supported by different brain areas.
#AlzheimersResearch#BrainHealth
https://t.co/D7TWJ4krNe
.@UCLAHealth researchers have found that switching to smaller vial sizes for the #Alzheimer’s drug lecanemab could save Medicare hundreds of millions annually, as nearly 6% of the drug is currently discarded, costing Medicare $1,600 per patient each year.
https://t.co/kofw8HUmNn
.@CedarsSinai has a new process that outlines safe, effective management of an Alzheimer’s drug, serving as a guide for administering complex therapies. A multidisciplinary team’s report details coordinated care for early-stage patients. #Alzheimers
https://t.co/AA8aD3o8Ly
.@CedarsSinai investigators led a study that found higher-than-average levels of two Alzheimer's-associated proteins—amyloid beta and tau—in the brain are linked with poorer cognition in adults 55 and younger
https://t.co/szpTGaF4sX
.@USCLeonardDavis received $3 million from the Administration for Community Living (ACL) to support family caregivers in maintaining financial stability and workplace security.
https://t.co/u9zhV00wDS
.@UCLAHealth researchers have identified and synthesized a molecule that was shown to restore cognitive functions in mice with Alzheimer’s disease symptoms by effectively jumpstarting the brain's memory circuitry.
#AlzheimersResearch#BrainHealth
https://t.co/AJpM59Nv8k
.@UCLAHealth researchers receive 9.5 million grant, from the National Institutes of Health (@NIH) with support from European funding agencies, to study relationship between polyphenol intake, #Alzheimers prevention, and the brain-gut-microbiome system.
https://t.co/ykYiMnY2HG
.@USCLeonardDavis Cheong and Mui Wong Endowed Research Fund for studying aging has grown exponentially with a new gift from Lisa and Linda Wong. Faculty will use the funds to research and address aging-related diseases.
https://t.co/QHm1fDPlrR
Register for the Geroscience Los Angeles Meeting (GLAM), a trainee-focused meeting, to help unite and synergize the geroscience community in the greater Los Angeles area through its trainees.
Follow the link to register 🎟️
https://t.co/0WOL3flcBa
#GLAM#Geroscience
.@UCLAHealth has been selected by the Centers for Medicare & Medicaid Services (@CMSGov) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.
https://t.co/auzinfGEbS
.@USCLeonardDavis study shows how transposons, “jumping genes”, are associated with age-related disease & decline, as well as how a transposon expression may be therapeutic targets for aging.
https://t.co/yf6GyhmiUx
.@USCLeonardDavis professor, Andrei Irimia, in collaboration with @USCViterbi student Benjamin Hacker (B.S. ’24), has developed a powerful machine learning model to predict concussion status in patients. #MachineLearning#BrainInjury
https://t.co/aPd4zhwcZG
.@CedarsSinai studies show that more precise control of electrical stimulation yields specific brain cell responses. This study could lead to new uses for the therapy that influence higher-level functions such as learning and #memory.
https://t.co/9d3Hev07EI
.@USCLeonardDavis study led by Asst. Prof. Michelle Keller (@michelleskeller) shows that providing brochures on benzodiazepine risks and ways to safely taper off of them can help older adults reduce their use of these medications.
https://t.co/r5ZIDg3wvt
.@CedarsSinai developed a #machinelearning tool that investigators can use to answer questions about genes, drugs, and biochemical pathways associated with #Alzheimer’s disease and other health conditions. This software is free and publicly available.
https://t.co/qNFpaEAdx9